{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:27:10Z","timestamp":1768638430482,"version":"3.49.0"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz. J. Pharm. Sci."],"DOI":"10.1590\/s2175-97902022e20380","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T14:34:01Z","timestamp":1669386841000},"source":"Crossref","is-referenced-by-count":2,"title":["Pharmacovigilance: an evaluation on the practice of pharmacists acting in pharmacies and drugstores"],"prefix":"10.1590","volume":"58","author":[{"given":"Mayra Bruna","family":"Fedalto","sequence":"first","affiliation":[{"name":"Federal University of Paran\u00e1,  Brazil"}]},{"given":"Fernanda Stumpf","family":"Tonin","sequence":"additional","affiliation":[{"name":"Federal University of Paran\u00e1,  Brazil; University of Lisbon,  Portugal"}]},{"given":"Helena Hiemisch Lobo","family":"Borba","sequence":"additional","affiliation":[{"name":"Federal University of Paran\u00e1,  Brazil"}]},{"given":"Vinicius Lins","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Federal University of Paran\u00e1,  Brazil"}]},{"given":"Cassyano Janu\u00e1rio","family":"Correr","sequence":"additional","affiliation":[{"name":"Federal University of Paran\u00e1,  Brazil"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-9595","authenticated-orcid":false,"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[{"name":"University of Lisbon,  Portugal; University of Porto,  Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4363","authenticated-orcid":false,"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[{"name":"Federal University of Paran\u00e1,  Brazil"}]}],"member":"530","published-online":{"date-parts":[[2022]]},"reference":[{"issue":"2","key":"ref1","first-page":"864","article-title":"Adverse drug reactions of statin based on patients\u2019 self reports","volume":"5","author":"AbdulRazzaq HA","year":"2012","journal-title":"J Pharm Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2147\/TCRM.S140674","article-title":"Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana\u2019a, Yemen","volume":"13","author":"Al-Worafi YM","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"ref3","first-page":"29","article-title":"Scenario of Pharmacovigilance and ADR Reporting among Pharmacists in Delhi","volume":"4","author":"Amrita P","year":"2011","journal-title":"Int J Pharm Pract"},{"key":"ref4","first-page":"75","article-title":"Attitude of community pharmacists in Saudi Arabia towards adverse drug reaction reporting","volume":"14","author":"Bawazir SA","year":"2006","journal-title":"Saudi Pharm J"},{"key":"ref5","first-page":"230","article-title":"Los limites del rol del farmac\u00e9utico: hasta d\u00f3nde debemos ir?","volume":"2","author":"Bonal J","year":"2001","journal-title":"Pharm Care Esp"},{"issue":"7452","key":"ref6","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bmj.328.7452.1372","article-title":"Administering, analysing, and reporting your questionnaire","volume":"328","author":"Boynton PM","year":"2004","journal-title":"BMJ"},{"key":"ref7","series-title":"Lei n\u00b013.021, de 8 de agosto de 2014. Disp\u00f5e sobre o exerc\u00edcio e a fiscaliza\u00e7\u00e3o das atividades farmac\u00eauticas","year":"2014"},{"key":"ref8","series-title":"Resolu\u00e7\u00e3o n\u00ba 6, de 19 de outubro de 2017. Institui as Diretrizes Curriculares Nacionais do Curso de Gradua\u00e7\u00e3o em Farm\u00e1cia e d\u00e1 outras provid\u00eancias","year":"2017"},{"key":"ref9","series-title":"Informe n\u00b0 01\/2019. Orienta\u00e7\u00f5es para notifica\u00e7\u00e3o no sistema VigiMed","year":"2019"},{"key":"ref10","series-title":"Notifica\u00e7\u00f5es em Vigil\u00e2ncia Sanit\u00e1ria - NOTIVISA","year":"2020"},{"issue":"37","key":"ref11","article-title":"Farmacovigil\u00e2ncia em farm\u00e1cias e drogarias: situa\u00e7\u00e3o atual","volume":"1","author":"Canibal NA","year":"2017","journal-title":"Rev Intellectus"},{"issue":"19","key":"ref12","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2146\/ajhp100077","article-title":"Economic effects of pharmacists on health outcomes in the United States: A systematic review","volume":"67","author":"Chisholm-Burns MA","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"ref13","series-title":"Dados 2018","year":"2018"},{"issue":"1","key":"ref14","first-page":"37","article-title":"Perfil de los farmac\u00e9uticos e indicadores de estrutura y proceso en farmacias de Curitiba - Brasil","volume":"2","author":"Correr CJ","year":"2004","journal-title":"Seguimiento Farmacoterap\u00e9utico"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/IPRP.S108047","article-title":"Role of the pharmacist in reducing healthcare costs: current insights","volume":"6","author":"Dalton K","year":"2017","journal-title":"Integr Pharm Res Pract"},{"issue":"1","key":"ref16","first-page":"31","article-title":"Evaluation of pharmaceutical services: Structure and process indicators in community pharmacies","volume":"17","author":"Fernandes BD","year":"2015","journal-title":"Rev Bras Pesq Sa\u00fade"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11096-010-9393-x","article-title":"Provision of pharmaceutical care by community pharmacists: a comparison across Europe","volume":"32","author":"Hughes CM","year":"2010","journal-title":"Pharm World Sci"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/03007995.2017.1361916","article-title":"Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon","volume":"34","author":"Hajj A","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902017000116021","article-title":"Quality indicators of pharmacists\u2019 services in community pharmacies in Paran\u00e1 State, Brazil","volume":"53","author":"J\u00fanior Hip\u00f3lito EH","year":"2017","journal-title":"Braz J Pharm Sci"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s11096-018-0700-2","article-title":"Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey","volume":"40","author":"Li R","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s11096-018-0671-3","article-title":"Reporting Adverse Drug Reactions: Contribution, Knowledge and Perception of German Pharmacy Professionals","volume":"40","author":"Laven A","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jsps.2013.07.005","article-title":"Community pharmacists\u2019 knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia","volume":"22","author":"Mahmoud MA","year":"2014","journal-title":"Saudi Pharm J"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/pds.2021","article-title":"The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria","volume":"20","author":"Oreagba IA","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"ref24","first-page":"222","article-title":"Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India","volume":"10","author":"Prakasam A","year":"2012","journal-title":"Pharm Pract"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0034-89102010005000050","article-title":"Estrat\u00e9gias para aumentar a sensibilidade da farmacovigil\u00e2ncia em Portugal","volume":"45","author":"Ribeiro-Vaz I","year":"2011","journal-title":"Rev de Sa\u00fade P\u00fablica"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0018578717715364","article-title":"Adverse drug reaction reporting practices among United Arab Emirates","volume":"52","author":"Said ASA","year":"2017","journal-title":"Hosp Pharm"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pds.3311","article-title":"Pharmacovigilance teaching in UK undergraduate pharmacy programmes","volume":"22","author":"Smith MP","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref28","series-title":"Auditoria operacional no controle p\u00f3s-registro de medicamentos","year":"2016"},{"key":"ref29","first-page":"1","article-title":"Quality evaluation of the Japanese Adverse Drug Event Report database (JADER)","author":"Tsuchiya M","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.6061\/clinics\/2017(01)09","article-title":"Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff","volume":"72","author":"Varallo FR","year":"2017","journal-title":"Clinics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11096-008-9276-6","article-title":"Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran","volume":"31","author":"Vessal G","year":"2009","journal-title":"Pharm World Sci"},{"key":"ref32","series-title":"The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products","year":"2002"},{"issue":"5","key":"ref33","article-title":"Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists","volume":"11","author":"Yu YM","year":"2016","journal-title":"PLOS ONE"}],"container-title":["Brazilian Journal of Pharmaceutical Sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S1984-82502022000100747&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T14:34:39Z","timestamp":1669386879000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1984-82502022000100747&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":33,"alternative-id":["S1984-82502022000100747"],"URL":"https:\/\/doi.org\/10.1590\/s2175-97902022e20380","relation":{},"ISSN":["2175-9790"],"issn-type":[{"value":"2175-9790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"e20380"}}